학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 407건 | 목록 1~20
Academic Journal
Ruiz de Azua G; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Licaj I; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.; Pinto S; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.; Havas J; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Di Meglio A; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Gustave Roussy, Medical Oncology Department, Villejuif, France.; Vaz-Luis I; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Gustave Roussy, Medical Oncology Department, Villejuif, France.; Pistilli B; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Gustave Roussy, Medical Oncology Department, Villejuif, France.; André F; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Gustave Roussy, Medical Oncology Department, Villejuif, France.; Martin AL; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France.; Everhard S; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France.; Jouannaud C; Institut Godinot, Reims, France.; Fournier M; Institut Bergonié, Bordeaux, France.; Rouanet P; Institut régional du cancer de Montpellier - Val d'Aurelle, Montpellier, France.; Dhaini-Merimeche A; Institut de cancérologie de Lorraine - Alexis Vautrin, Vandoeuvre lès Nancy, France.; Sauterey B; Institut de Cancérologie de L'ouest -Site Angers, Angers, France.; Campone M; Institut de Cancérologie de l'Ouest - Site de Nantes, Nantes Saint Herblin, France.; Tarpin C; Institut Paoli-Calmettes, Marseille, France.; Lerebours F; Institut CURIE - Site de Saint Cloud, Saint Cloud, France.; Dumas A; INSERM, Aix Marseille Univ, IRD, ISSPAM, SESSTIM (Economic and Social Sciences of Health and Medical Information Processing), CALIPSO team, Marseille, France.; Menvielle G; University Paris Saclay, Gustave Roussy Institute, INSERM, Molecular Predictors and New Targets in Oncology, Villejuif, France. gwenn.menvielle@inserm.fr.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Academic Journal
Pagliuca M; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Departement of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale,' Napoli, Italia.; Havas J; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Thomas E; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France.; Drouet Y; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France.; Soldato D; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Franzoi MA; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Ribeiro J; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Chiodi CK; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Gillanders E; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Pistilli B; Medical Oncology Department, INSERM U981, Gustave Roussy, Villejuif, France.; Menvielle G; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Joly F; Clinical Research Department, INSERM U1086 Anticipe, Centre Francois Baclesse, University UniCaen, Caen, France.; Lerebours F; Medical Oncology Department, Institut Curie Saint Cloud, Saint Cloud, France.; Rigal O; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.; Petit T; Medical Oncology Department, Institute of Cancer Strasbourg, Strasbourg, France.; Giacchetti S; Department of Breast Disease, APHP, University Hospital Saint Louis, Senopole, Paris, France.; Dalenc F; Medical Oncology Department, Oncopole Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.; Wassermann J; Medical Oncology Department, Pitié Salpêtrière University Hospital, Cancer University Institute, AP-HP, Paris, France.; Arsene O; Medical Oncology Department, Centre Hospitalier de Blois, Blois, France.; Martin AL; Direction des Data et des Partenariats, UNICANCER, Paris, France.; Everhard S; Direction des Data et des Partenariats, UNICANCER, Paris, France.; Tredan O; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France.; Boyault S; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France.; De Laurentiis M; Departement of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale,' Napoli, Italia.; Viari A; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France.; Deleuze JF; Centre National de Recherche en Génomique Humaine CNRGH-CEA, Laboratory of Excellence in Medical Genomics, GENMED, Évry-Courcouronnes, France.; Bertaut A; Unit of Methodology and Biostatistics, George-François Leclerc Cancer Center, Dijon, France.; André F; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Vaz-Luis I; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways, Gustave Roussy, Villejuif, France.; Di Meglio A; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Franzoi MA; Cancer Survivorship Group, Inserm Unit 981, Gustave Roussy, Villejuif, France. Electronic address: Mariaalice.borinelli-franzoi@gustaveroussy.fr.; Pages A; OncoStat, Gustave Roussy, Villejuif, France.; Charles C; Direction general de la Cohesion sociale (DGCS), Paris, France.; Debiasi M; Champalimaud Hospital, Lisbon, Portugal.; Gillanders E; Cancer Survivorship Group, Inserm Unit 981, Gustave Roussy, Villejuif, France.; Ferreira A; Resilience Care, Paris, France.; Jacques F; Resilience Care, Paris, France.; Everhard S; WeShare Platform, Data Department, UNICANCER, Paris, France.; GaryBobo G; WeShare Platform, Data Department, UNICANCER, Paris, France.; Sambou C; Équipe PHARES, Centre de recherche Bordeaux Population Health, Inserm Unit 1219, Université de Bordeaux, France.; Alla F; Équipe PHARES, Centre de recherche Bordeaux Population Health, Inserm Unit 1219, Université de Bordeaux, France.; Quivy A; Supportive Care Department, CHU Bordeaux, Bordeaux, France.; Morin S; Supportive Care Department, Institut Bergonié, Bordeaux, France.; Vaz-Luis I; Cancer Survivorship Group, Inserm Unit 981, Gustave Roussy, Villejuif, France; Department for the Organization of Patient Pathways, Gustave Roussy, Villejuif, France.
Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Academic Journal
Serghani MM; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Kassem-Moussa S; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon; Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Hadath, Beirut, Lebanon; Doctoral School of Sciences and Technology, Lebanese University, Hadath, Beirut, Lebanon.; Makki R; Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Hadath, Beirut, Lebanon.; Kurdi A; Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Elbaset M; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Neurology, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN, United States.; Hajjar H; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Jammal RE; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States.; Flath-Everhard GT; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States.; Prasad I; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States.; Eid A; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Habib A; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.; Hamade E; Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Hadath, Beirut, Lebanon; Platform for Research and Analysis in Environmental Sciences, Doctoral School of Sciences and Technology, Lebanese University, Hadath, Beirut, Lebanon. Electronic address: eva.hamade@ul.edu.lb.; White FA; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN, United States.; Badran B; Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Hadath, Beirut, Lebanon.; Obeid M; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Neurology, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN, United States. Electronic address: makobeid@iu.edu.
Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7972 (Electronic) Linking ISSN: 03043940 NLM ISO Abbreviation: Neurosci Lett Subsets: MEDLINE
Academic Journal
Grammoustianou M; Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Maccarone S; Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; University of Pavia, Pavia, Italy.; Gillanders E; Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Menvielle G; Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Preau M; Inserm U1296, Radiations: Santé, Défense, Environnement (Radiation: Health, Defense, Environment), University Lumière Lyon 2, France.; Ginguene S; Inserm U1296, Radiations: Santé, Défense, Environnement (Radiation: Health, Defense, Environment), University Lumière Lyon 2, France.; Everhard S; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France.; Delpierre C; CERPOP, Université Toulouse III-Paul Sabatier, Toulouse, France.; Guillemin F; CHRU-Nancy, Inserm, Université de Lorraine, CIC, Epidémiologie Clinique, 54000, Nancy, France.; UMR INSPIIRE, Université de Lorraine, Inserm, Nancy, France.; Vaz-Luis I; Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France.; Franzoi MA; Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Academic Journal
Chiodi C; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France. camilakchiodi@gmail.com.; Epstein J; Université de Lorraine, APEMAC, Nancy, France.; REFLIS, Paris, France.; French National Platform Quality of Life and Cancer, Paris, France.; Arvis J; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Martin E; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Barbier A; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Di Meglio A; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Gillanders E; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Jacob G; Seintinelles, Paris, France.; Menvielle G; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Everhard S; UNICANCER, Paris, France.; Guillemin F; Université de Lorraine, APEMAC, Nancy, France.; REFLIS, Paris, France.; French National Platform Quality of Life and Cancer, Paris, France.; Luis IV; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Inserm Unit 981 Gustave Roussy, Villejuif, France.; Franzoi MA; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.
Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE
Academic Journal
Caumette E; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Sante Publique, Paris, France.; Department of Maieutics, Université de Montpellier, Montpellier, France.; Di Meglio A; INSERM Unit U 981, Villejuif, France.; Breast Cancer Unit, Department of Cancer Medecine, Gustave Roussy, Villejuif, France.; Vaz-Luis I; INSERM Unit U 981, Villejuif, France.; Breast Cancer Unit, Department of Cancer Medecine, Gustave Roussy, Villejuif, France.; Charles C; Bordeaux Population Health Research Center (U1219), Université de Bordeaux, Bordeaux, France.; Havas J; INSERM Unit U 981, Villejuif, France.; Breast Cancer Unit, Department of Cancer Medecine, Gustave Roussy, Villejuif, France.; Clinical Research Department, Gustave Roussy, Villejuif, France.; de Azua GR; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Sante Publique, Paris, France.; Martin E; INSERM Unit U 981, Villejuif, France.; Vanlemmens L; Centre Oscar Lambret, Lille, France.; Delaloge S; INSERM Unit U 981, Villejuif, France.; Everhard S; Unicancer, Paris, France.; Martin AL; Unicancer, Paris, France.; Merimeche AD; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France.; Rigal O; Centre Henri Becquerel, Rouen, France.; Coutant C; Centre George François Leclerc, Dijon, France.; Fournier M; Institut Bergonié, Bordeaux, France.; Jouannaud C; Institut Jean Godinot Reims, Reims, France.; Soulie P; Institut de Cancérologie de L'Ouest - Centre Paul Papin, Angers, France.; Cottu PH; Institut Curie, Paris, France.; Tredan O; Centre Léon Bérard, Lyon, France.; Menvielle G; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Sante Publique, Paris, France.; Dumas A; Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France. agnes.dumas@inserm.fr.
Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE
Academic Journal
Martin E; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Chichua M; University of Milan, Milan, Italy.; European Insitute of Oncology IRCCS, Milan, Italy.; Chiodi CK; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Zyumbileva P; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Lapidari P; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Pagliuca M; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Scuola Superiore Meridionale, Naples, Italy.; Gillanders E; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Barbier A; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France.; Bertaut A; Centre Georges-François Leclerc, Dijon, France.; Boinon D; Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France.; Laboratoire de Psychopathologie Et Processus de Santé, Université Paris Cité, F-92100, Boulogne-Billancourt, France.; Martin AL; UNICANCER, Paris, France.; Everhard S; UNICANCER, Paris, France.; Golli L; UNICANCER, Paris, France.; Jouannaud C; Institut Godinot, Reims, France.; Kaderbhai C; Centre Georges-François Leclerc, Dijon, France.; Mery B; Centre Léon Bérard, Lyon, France.; Rigal O; Centre Henri Becquerel, Rouen, France.; Franzoi MA; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Vaz-Luis I; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France.; Di Meglio A; Université Paris-Saclay, Gustave Roussy, Inserm, CESP, F-94805, Villejuif, France. antonio.DI-MEGLIO@gustaveroussy.fr.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Elbaset M; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.; Jammal RE; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Khan N; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Yeh IJ; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Looney A; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Nguyen T; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN, USA.; Al-Juboori MH; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN, USA.; Flath-Everhard GT; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Conrad S; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.; Abramovici S; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.; Yoshida K; Department of Biomedical Engineering, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA.; Oblak AL; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; White FA; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN, USA.; Obeid M; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA. makobeid@iu.edu.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. makobeid@iu.edu.; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. makobeid@iu.edu.
Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Everhard, A. S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어